🔴 Cerenome is trading 5.7% down amid broader healthcare weakness

Cerenome is trading 5.7% down at $1.65 on October 23, 2026, amid broader healthcare weakness, though no direct company-specific link is confirmed.

• The healthcare sector is down 1.29%, amid concern following Quest Diagnostics’ reported cyberattack.
• No new company announcement dated October 23 was identified. Cerenome’s latest listed release, dated October 21, covered preclinical REYOBIQ data and does not establish a clear catalyst for today’s decline.